300942.SZ · 易瑞生物
China A-shares · RS rating 39 · As of 2026-10-14
| Price | 6.45 CNY |
|---|---|
| 1-day change | -2.9% |
| RS rating (overall / 1M / 3M / 12M) | 39 / 71 / 66 / 12 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 9 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +22.7% |
| Distance from 52-week high | +42.0% |
| Market cap (USD) | $401.6M |